Evidence map›Paper›PMID 38463741›Full record

ArticleJournal of surgical case reports2024

Anterior segment migration of intravitreal dexamethasone implant in a patient with scleral fixation intraocular lens implant: a case report.

Hani B ALBalawi, Naif M Alali, Abdullah H Altemani, Moustafa S Magliyah, Khaled S ASharari, Maram S ALRubayyi, Faris Hashem, Saad H Alenezi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of surgical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hani B ALBalawiDivision of Ophthalmology, Department of Surgery, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia.
Naif M AlaliDivision of Ophthalmology, Department of Surgery, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia.
Abdullah H AltemaniDepartment of Family and Community Medicine, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia.
Moustafa S MagliyahVitreoretinal Division, King Khaled Eye Specialist Hospital, Riyadh 12329, Saudi Arabia.
Khaled S ASharariVitreoretinal Division, King Khaled Eye Specialist Hospital, Riyadh 12329, Saudi Arabia.
Maram S ALRubayyiRadiology Department, Security Force Hospital, Riyadh 11564, Saudi Arabia.
Faris HashemDivision of Ophthalmology, Department of Surgery, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID https://orcid.org/0000-0002-8817-1095
Saad H AleneziDepartment of Ophthalmology, Majmaah University, Majmaah 15341, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corticosteroids are crucial for treating inflammatory ocular conditions. The development of dexamethasone revolutionized targeted ocular therapy. Ozurdex, a dexamethasone implant, effectively treats various eye conditions but carries risks such as implant migration. This is a case of anterior segment migration of intravitreal dexamethasone implant, Ozurdex, in a patient with scleral fixation intraocular lens implant in whom conservative management with supine positioning and pharmacologic pupil dilation can help retain the implant back in the vitreous. Patients at high risk of Ozurdex migration should avoid its use. Educate patients on the risk of implant migration and signs of migration to present immediately to an ophthalmology emergency department to avoid corneal damage. It is essential to identify high-risk patients before considering Ozurdex migration. In some cases, conservative management can be initiated while preparing for surgical removal.

Indexed as

conservative managementdexamethasonemacular edemaOzurdex complicationsOzurdex implant migration

Identifiers

PMID38463741
PMCPMC10924725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.